7Baggers
 Arvinas to Present Clinical Data for ARV-102, a PROTAC  GlobeNewswire Wed, 01 Oct 2025 11:03:36 GMT
 Arvinas and Pfizer seek a new home for protein degrader drug  Chemistry World Tue, 30 Sep 2025 15:00:00 GMT
 Arvinas, Inc. $ARVN Shares Sold by Assenagon Asset Management S.A.  MarketBeat Mon, 29 Sep 2025 07:18:53 GMT
 published on: 2025-09-26 16:36:13  newser.com Fri, 26 Sep 2025 21:36:13 GMT
 Arvinas (NASDAQ:ARVN) Trading 4.9% Higher - What's Next?  MarketBeat Fri, 26 Sep 2025 19:23:32 GMT
 Local biotech firm Arvinas refocusing after turbulent stretch  Yale Daily News Fri, 26 Sep 2025 09:16:25 GMT
 Director Makes Major Investment in Arvinas Holding Company!  TipRanks Thu, 25 Sep 2025 02:04:02 GMT
 Arvinas director Morrison Briggs buys $227k in shares  Investing.com Wed, 24 Sep 2025 07:00:00 GMT
 Arvinas (NASDAQ:ARVN) Director Briggs Morrison Buys 30,000 Shares  MarketBeat Wed, 24 Sep 2025 07:00:00 GMT
 Arvinas (NASDAQ:ARVN) Downgraded by Bank of America to "Neutral"  MarketBeat Wed, 24 Sep 2025 07:00:00 GMT
 Arvinas stock downgraded by BofA as Pfizer partnership shifts  Investing.com Wed, 24 Sep 2025 07:00:00 GMT
 arvinas, inc. $arvn shares sold by goldman sachs group inc.  MarketBeat Wed, 24 Sep 2025 02:39:51 GMT
 arvinas downgraded to neutral from buy at bofa  TipRanks Wed, 24 Sep 2025 00:39:57 GMT
 arvinas downgraded to neutral from buy at bofa  TipRanks Tue, 23 Sep 2025 23:38:52 GMT
 arvinas (nasdaq:arvn) given neutral rating at wedbush  MarketBeat Tue, 23 Sep 2025 10:03:49 GMT
 arvinas (nasdaq:arvn) upgraded by barclays to "strong-buy" rating  MarketBeat Tue, 23 Sep 2025 09:53:48 GMT
 arvinas (nasdaq:arvn) price target lowered to $14.00 at stephens  MarketBeat Tue, 23 Sep 2025 07:42:31 GMT
 arvinas (nasdaq:arvn) to repurchase $100.00 million in shares  MarketBeat Tue, 23 Sep 2025 07:41:15 GMT
 arvinas, inc. $arvn shares sold by goldman sachs group inc.  MarketBeat Tue, 23 Sep 2025 07:00:00 GMT
 arvinas (nasdaq:arvn) upgraded by barclays to strong-buy rating  MarketBeat Tue, 23 Sep 2025 04:45:26 GMT
 arvinas (nasdaq:arvn) upgraded by barclays to strong-buy rating  MarketBeat Mon, 22 Sep 2025 19:43:24 GMT
 arvinas (nasdaq:arvn) coverage initiated by analysts at barclays  MarketBeat Mon, 22 Sep 2025 08:31:14 GMT
 stephens cuts arvinas (nasdaq:arvn) price target to $14.00  MarketBeat Mon, 22 Sep 2025 08:31:11 GMT
 wedbush reiterates "neutral" rating for arvinas (nasdaq:arvn)  MarketBeat Mon, 22 Sep 2025 07:08:43 GMT
 arvinas (nasdaq:arvn) rating increased to strong-buy at barclays  MarketBeat Mon, 22 Sep 2025 07:08:38 GMT
 Arvinas (NASDAQ:ARVN) Given Neutral Rating at Wedbush  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 Arvinas (NASDAQ:ARVN) Price Target Lowered to $14.00 at Stephens  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 Arvinas (NASDAQ:ARVN) Upgraded by Barclays to "Strong-Buy" Rating  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 arvinas (nasdaq:arvn) to repurchase $100.00 million in shares  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 arvinas, inc. $arvn shares sold by goldman sachs group inc.  MarketBeat Mon, 22 Sep 2025 05:35:16 GMT
 arvinas announces $100m share repurchase program  MSN Mon, 22 Sep 2025 01:25:48 GMT
 Arvinas (NASDAQ:ARVN) Coverage Initiated by Analysts at Barclays  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 wedbush reiterates "neutral" rating for arvinas (nasdaq:arvn)  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 arvinas (nasdaq:arvn) rating increased to strong-buy at barclays  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 stephens cuts arvinas (nasdaq:arvn) price target to $14.00  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 arvinas announces $100m share repurchase program  MSN Sun, 21 Sep 2025 01:50:42 GMT
 arvinas announces $100m share repurchase program  MSN Sat, 20 Sep 2025 22:17:19 GMT
 arvinas, inc. $arvn shares sold by goldman sachs group inc.  MarketBeat Sat, 20 Sep 2025 22:07:30 GMT
 goldman sachs group inc. reduces stake in arvinas, inc. $arvn  MarketBeat Sat, 20 Sep 2025 07:28:06 GMT
 share buyback plan announced by arvinas (nasdaq:arvn)  MarketBeat Sat, 20 Sep 2025 02:07:58 GMT
 arvinas (nasdaq:arvn) earns neutral rating from wedbush  MarketBeat Fri, 19 Sep 2025 15:29:49 GMT
 arvinas (nasdaq:arvn) earns "neutral" rating from wedbush  MarketBeat Fri, 19 Sep 2025 15:29:49 GMT
 btig research cuts arvinas (nasdaq:arvn) price target to $10.00  MarketBeat Fri, 19 Sep 2025 14:34:19 GMT
 stephens lowers arvinas (nasdaq:arvn) price target to $14.00  MarketBeat Fri, 19 Sep 2025 12:34:30 GMT
 arvinas (nasdaq:arvn) given new $14.00 price target at stephens  MarketBeat Fri, 19 Sep 2025 12:34:30 GMT
 arvinas (nasdaq:arvn) raised to strong-buy at barclays  MarketBeat Fri, 19 Sep 2025 11:22:17 GMT
 arvinas (nasdaq:arvn) upgraded to strong-buy at barclays  MarketBeat Fri, 19 Sep 2025 11:22:17 GMT
 Arvinas reboots, cuts more staff; Porges joins Lazard  BioPharma Dive Fri, 19 Sep 2025 07:00:00 GMT
 btig maintains buy rating on arvinas (arvn) despite lowered pric  GuruFocus Thu, 18 Sep 2025 14:36:57 GMT
 arvn: stephens & co. lowers price target, maintains overweight r  GuruFocus Thu, 18 Sep 2025 12:41:44 GMT
 arvinas (nasdaq:arvn) now covered by analysts at barclays  MarketBeat Thu, 18 Sep 2025 12:16:01 GMT
 arvinas (arvn) announces $100m share buyback plan  GuruFocus Thu, 18 Sep 2025 07:01:05 GMT
 Pfizer, Arvinas change course on vepdegestrant despite recent FDA filing  FirstWord Pharma Thu, 18 Sep 2025 07:00:00 GMT
 Arvinas amends collaboration with Pfizer  The Pharma Letter Thu, 18 Sep 2025 07:00:00 GMT
 Vepdegestrant Up For Grabs As Pfizer And Arvinas Step Aside  insights.citeline.com Thu, 18 Sep 2025 07:00:00 GMT
 Arvinas stock rises as Cantor Fitzgerald reaffirms Overweight rating  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 arvinas price target lowered to $14 from $16 at stephens  TipRanks Thu, 18 Sep 2025 07:00:00 GMT
 arvinas price target lowered to $10 from $16 at btig  TipRanks Thu, 18 Sep 2025 07:00:00 GMT
 arvinas announces $100m share repurchase program  MSN Thu, 18 Sep 2025 06:29:03 GMT
 arvinas and pfizer to out-license breast cancer drug vepdegestrant by investing.com  Investing.com South Africa Thu, 18 Sep 2025 00:37:54 GMT
 oppenheimer maintains arvinas(arvn.us) with hold rating  富途牛牛 Thu, 18 Sep 2025 00:32:00 GMT
 arvinas (arvn) and pfizer shift commercialization strategy for c  GuruFocus Wed, 17 Sep 2025 22:00:03 GMT
 arvinas (arvn) refocuses strategy and optimizes costs after stra  GuruFocus Wed, 17 Sep 2025 21:51:54 GMT
 pfizer (pfe) and arvinas seek partner for vepdegestrant's commer  GuruFocus Wed, 17 Sep 2025 21:47:52 GMT
 arvinas expects $4.5 million costs for workforce reduction - sec filing  MarketScreener Wed, 17 Sep 2025 21:33:37 GMT
 arvinas to reduce workforce by 15%  TipRanks Wed, 17 Sep 2025 20:46:28 GMT
 Barclays initiates coverage on Arvinas stock with Overweight rating  Investing.com Wed, 17 Sep 2025 07:00:00 GMT
 arvinas and pfizer to out-license breast cancer drug vepdegestrant  Investing.com Wed, 17 Sep 2025 07:00:00 GMT
 arvinas announces $100m share repurchase program  TipRanks Wed, 17 Sep 2025 07:00:00 GMT
 arvinas assumed with an overweight at barclays  TipRanks Tue, 16 Sep 2025 21:52:36 GMT
 invesco ltd. acquires 44,493 shares of arvinas, inc. $arvn  MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
 arvinas, inc. $arvn position boosted by invesco ltd.  MarketBeat Tue, 09 Sep 2025 23:24:10 GMT
 invesco ltd. buys 44,493 shares of arvinas, inc. $arvn  MarketBeat Tue, 09 Sep 2025 10:03:32 GMT
 arvinas, inc. $arvn shares acquired by invesco ltd.  MarketBeat Sun, 07 Sep 2025 08:50:29 GMT
 invesco ltd. boosts stock position in arvinas, inc. $arvn  MarketBeat Sun, 07 Sep 2025 08:50:29 GMT
 nuveen llc buys shares of 166,597 arvinas, inc. $arvn  MarketBeat Sat, 06 Sep 2025 22:48:32 GMT
 graham capital management l.p. grows stake in arvinas, inc. $arvn  MarketBeat Sat, 06 Sep 2025 20:41:05 GMT
 nuveen llc buys new stake in arvinas, inc. $arvn  MarketBeat Sat, 06 Sep 2025 10:08:35 GMT
 nuveen llc invests $1.17 million in arvinas, inc. $arvn  MarketBeat Sat, 06 Sep 2025 07:00:00 GMT
 nuveen llc buys new stake in arvinas, inc. $arvn  MarketBeat Fri, 05 Sep 2025 22:26:33 GMT
 nuveen llc invests $1.17 million in arvinas, inc. $arvn  MarketBeat Fri, 05 Sep 2025 07:55:45 GMT

Arvinas, Inc
(NASDAQ:ARVN) 

ARVN stock logo

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical tri...

Founded: 2013
Full Time Employees: 133
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends